Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Prof. Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Professor | Shuang Ho Hospital, Taipei Medical University | Taiwan

Dr. Ming Yow Hung is a distinguished researcher at Taipei Medical University, Taiwan, specializing in cardiovascular biology, molecular cardiology, and stem cell research. His work focuses on understanding coronary artery disorders, including vasospasm, Kounis syndrome, and allergic myocardial infarction, through experimental, translational, and epigenetic approaches. He has authored numerous peer-reviewed publications, with significant citation impact reflecting his influence in cardiovascular and pharmaceutical research. Dr. Hung collaborates extensively with international teams, contributing to multidisciplinary studies that integrate molecular mechanisms, induced pluripotent stem cell models, and clinical insights. His research advances understanding of disease mechanisms and informs therapeutic strategies, with clear societal relevance in improving cardiovascular health, personalized medicine, and patient care, positioning him as a globally recognized and impactful scientist in cardiovascular research.

Citation Metrics (Scopus)

1,824
1,400
900
450
0

Citations

1,824

Documents

57

h-index

20

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Beatriz Estalayo Gutiérrez | Medicine and Dentistry | Best Research Article Award

Published on by Global Scholar Awards

Mrs. Beatriz Estalayo Gutiérrez | Medicine and Dentistry | Best Research Article Award

Médico de Familia at SERMAS, Spain

Beatriz Estalayo Gutiérrez, a Family Physician with a PhD in Medicine, is a strong candidate for the Best Research Article Award due to her innovative research in mental health, specifically through auditory interventions in primary care. Her work, including the development of the Frequency Modulated Auditory Intervention, addresses anxiety and depression using novel auditory modulation techniques, which have been evaluated in controlled clinical trials and published in reputable journals. Her academic credentials are complemented by significant international experience with Médecins Sans Frontières, where she provided care in conflict zones. While her research has had an important impact, her citation index (H-index of 2) suggests potential for broader influence, and she could benefit from more collaborative research efforts and increased visibility at international conferences. Nevertheless, her contributions to the field of mental health, especially in low-resource settings, make her a deserving candidate for the award.

Professional Profile 

Education🎓

Beatriz Estalayo Gutiérrez holds a PhD in Medicine from the University of Alcalá, completed between 2016 and 2021, where she focused on anxiety and depression in primary care, specifically through auditory interventions. In addition to her doctoral studies, she earned a Master’s Degree in Humanitarian Medicine from CEIC, Complutense University (2006-2007), and a Diploma in Epidemiology and Public Health from Rey Juan Carlos University (2004-2007). She also holds a Bachelor’s Degree in Medicine from UAM, obtained between 1997 and 2003. Her academic training blends medical practice with research, particularly in the fields of mental health and humanitarian medicine. This diverse educational background has equipped her with a deep understanding of both clinical and research aspects of medicine, allowing her to contribute significantly to the study of mental health interventions in primary care settings. Beatriz’s education has laid a strong foundation for her ongoing work in medical research and healthcare.

Professional Experience📝

Beatriz Estalayo Gutiérrez has extensive professional experience as a family physician, with over 16 years of practice in primary care since 2004. She has been a key part of the SERMAS Servicio Madrileño de Salud since 2007, where she has honed her expertise in family medicine, focusing on mental health issues. In addition to her work in Spain, Beatriz has gained significant international experience through her involvement with Médecins Sans Frontières (MSF). She has worked in various crisis regions, including the Turkey-Syria border, the Tunisia-Lebanon border, Port-au-Prince, Haiti, and Madaoua, Niger, providing medical care to displaced populations and those affected by epidemics and natural disasters. This diverse experience has provided her with a global perspective on healthcare delivery in low-resource settings. Beatriz’s combination of clinical experience and humanitarian work has enriched her approach to patient care, particularly in addressing mental health challenges in underserved communities.

Research Interest🔎

Beatriz Estalayo Gutiérrez’s research interests primarily focus on mental health, particularly in primary care settings. Her work explores innovative approaches to treating anxiety and depression, with a specific emphasis on auditory interventions. Beatriz has developed and evaluated the Frequency Modulated Auditory Intervention, which has been tested in controlled clinical trials to assess its effectiveness in modulating auditory perception and improving mental health outcomes. Her research aims to bridge the gap between sensory processing and mental health therapies, highlighting the potential of auditory modulation techniques in treating common mental health conditions. Additionally, Beatriz is interested in the interplay between auditory perception asymmetries and mental health disorders, such as anxiety and depression. Her work contributes to a deeper understanding of how auditory interventions can be used as a therapeutic tool in primary care, offering new insights into improving the mental well-being of patients, especially in underserved populations.

Award and Honor🏆

Beatriz Estalayo Gutiérrez has not yet received major formal awards or honors, but her work has been recognized in the academic and medical communities, particularly for her innovative contributions to mental health research. Her publications, including her research on auditory interventions in the treatment of anxiety and depression, have been published in reputable journals such as the Journal of Clinical Medicine and Symmetry, contributing to her growing recognition in the field of primary care and mental health. Her research has also been cited internationally, indicating a growing influence in the medical and scientific communities. Although she has not yet received a specific award, her continuous academic and professional contributions demonstrate her commitment to advancing healthcare, particularly in the intersection of sensory processing and mental health. Her dedication to improving patient care, especially in underserved settings, highlights her potential for future recognition and awards in the medical research field.

Research Skill🔬

Beatriz Estalayo Gutiérrez possesses strong research skills, particularly in the areas of clinical trials, mental health interventions, and auditory perception. Her ability to design and conduct controlled and randomized clinical trials is evident in her work on the Frequency Modulated Auditory Intervention, which targets anxiety and depression in primary care settings. She demonstrates expertise in data analysis and the development of innovative intervention techniques that bridge sensory processing with mental health treatment. Beatriz’s interdisciplinary knowledge spans from clinical medicine to public health and epidemiology, allowing her to apply diverse methodologies in her research. Her proficiency in publishing findings in peer-reviewed journals further showcases her ability to communicate complex research outcomes effectively to the global scientific community. Additionally, her experience with international humanitarian missions, such as those with Médecins Sans Frontières, adds a unique perspective to her research, particularly in addressing mental health in low-resource and crisis settings.

Conclusion💡

Beatriz Estalayo Gutiérrez is a highly promising candidate for the Best Research Article Award, with her innovative approach to addressing mental health issues through auditory interventions in primary care. Her work has the potential to reshape mental health treatments, particularly in low-resource settings. However, there is room for growth in her citation index and in expanding her collaborative research efforts. Overall, her research has substantial value in both academic and clinical contexts, making her a strong contender for the award.

Publications Top Noted✍️

  • Authors: Beatriz Estalayo-Gutiérrez, María José Álvarez-Pasquín, Francisco Germain

  • Year: 2025

  • Title: Approach to Mental Health Through a Frequency Modulated Auditory Intervention: A Controlled and Randomized Clinical Trial

  • Journal: Journal of Clinical Medicine

  • DOI: 10.3390/jcm14010288

Marília Dourado | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Marília Dourado | Medicine and Dentistry | Best Researcher Award

Professora Doutora at Faculdade de Medicina- Universidade de Coimbra, Portugal

Marília de Assunção Rodrigues Ferreira Dourado is an esteemed researcher and professor at the Faculty of Medicine, University of Coimbra. With extensive contributions in palliative care, pain medicine, and oncobiology, she has played a key role in advancing research on symptom control, pharmacological prescriptions, and cost-effectiveness in healthcare. She has authored over 30 peer-reviewed journal articles, 15 book chapters, and 162 conference abstracts, highlighting her dedication to academic excellence. Additionally, she has mentored over 70 master’s and PhD students, fostering the next generation of healthcare researchers.

Professional Profile 

Education

Marília Dourado holds a distinguished academic background in medicine and research. She is a Professor with Aggregation at the Faculty of Medicine, University of Coimbra, and possesses Competence in Experimental Pathology from the Portuguese Medical Association. Her commitment to palliative care education and research is evident through the programs she has established, such as the Master’s in Continuing and Palliative Care and the Postgraduate Program in Pain Medicine.

Professional Experience

With a robust career in academia and research, Marília Dourado is a Professor at the Faculty of Medicine, University of Coimbra, where she teaches and coordinates multiple programs. She established the Center for Studies and Development of Palliative Care (CEDCP) and leads research on biomarkers for pain, symptom control, and caregiver support. She is also an active member of the International Association for Hospice and Palliative Care (IAHPC), contributing to global advancements in palliative medicine.

Research Interest

Marília de Assunção Rodrigues Ferreira Dourado’s research primarily focuses on palliative care, pain medicine, and oncobiology. She has made significant contributions in symptom control, pharmacological prescriptions for end-of-life care, and the cost-effectiveness of palliative treatments. Her work also includes the development and validation of health measurement instruments, ensuring accurate assessment in clinical settings. Additionally, she explores biomarkers for pain diagnosis and treatment, aiming to improve pain management strategies. Her research extends to training and supporting informal caregivers, emphasizing the importance of holistic care in palliative settings.

Awards and Honors

Marília Dourado has been recognized for her contributions to medical research, education, and healthcare innovation. She has received accolades for her work in palliative care development, research excellence, and academic leadership. Her role in creating and coordinating specialized programs has earned her professional recognition both nationally and internationally. As a member of the International Association for Hospice and Palliative Care (IAHPC), she continues to influence the field globally.

Research Skills

Marília Dourado possesses a diverse set of research skills spanning clinical research, health assessment methodologies, and pharmacological studies. She specializes in qualitative and quantitative research methods, systematic reviews, and clinical trial design. Her expertise includes biomarker identification for pain, validation of health measurement instruments, and cost-effectiveness analysis in palliative care. Additionally, she is adept at mentoring researchers, designing curriculum-based research programs, and publishing in high-impact journals. Her interdisciplinary approach enables her to bridge clinical practice with innovative healthcare solutions.

Conclusion

Marília de Assunção Rodrigues Ferreira Dourado is a highly qualified and impactful researcher in palliative care, pain medicine, and oncobiology, making her a strong candidate for the Best Researcher Award. Her leadership in academic programs, research contributions, and mentoring efforts support her candidacy. To further strengthen her position, she could focus on increasing high-impact publications, securing major research grants, and expanding international collaborations.

Publications Top Noted

  • Opioids and Constipation Therapy in the Last Week of Life: Their Impact on Patients, Caregivers, and the Location of Death
    Authors: Ribeiro H, Magalhães J, Cardoso T, Chaves-Castro I, Lopes-Mota C, Costa E, Rocha P, Lopes L, Bouça Â, Pereira C, Dourado M et al.
    Year: 2023
    Citation: Ribeiro H et al., Medicine, 2023, DOI: 10.1097/md.0000000000032718

  • Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia
    Authors: Ribeiro H, Alves R, Jorge J, Gonçalves AC, Sarmento-Ribeiro AB, Teixeira-Veríssimo M, Dourado M, Andrade JP
    Year: 2023
    Citation: Ribeiro H et al., Biomedicines, 2023, DOI: 10.3390/biomedicines11020380

  • “Dignity as a Small Candle Flame That Doesn’t Go Out!”: An Interpretative Phenomenological Study with Patients Living with Advanced Chronic Obstructive Pulmonary Disease
    Authors: Laranjeira C, Dourado M
    Year: 2022
    Citation: Laranjeira C & Dourado M, International Journal of Environmental Research and Public Health, 2022, DOI: 10.3390/ijerph192417029

  • Novel Non-Viral Vectors Based on Pluronic® F68PEI with Application in Oncology Field
    Authors: Silva I, Domingues C, Jarak I, Carvalho RA, Cordeiro RA, Dourado M, Veiga F, Faneca H, Figueiras A
    Year: 2022
    Citation: Silva I et al., Polymers, 2022, DOI: 10.3390/polym14235315

  • Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology
    Authors: Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A
    Year: 2022
    Citation: Domingues C et al., ACS Nano, 2022, DOI: 10.1021/acsnano.2c00128

  • Apoptosis and (in) Pain-Potential Clinical Implications
    Authors: Ribeiro H, Sarmento-Ribeiro AB, Andrade JP, Dourado M
    Year: 2022
    Citation: Ribeiro H et al., Biomedicines, 2022, DOI: 10.3390/biomedicines10061255

  • Prescription Trends at the End of Life in a Palliative Care Unit: Observational Study
    Authors: Peralta T, Castel-Branco MM, Reis-Pina P, Figueiredo IV, Dourado M
    Year: 2022
    Citation: Peralta T et al., BMC Palliative Care, 2022, DOI: 10.1186/s12904-022-00954-z

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain and Aging: Adjusting Prescription to Patient Features
    Authors: Ribeiro H, Rodrigues I, Napoleão L, Lira L, Marques D, Veríssimo M, Andrade JP, Dourado M
    Year: 2022
    Citation: Ribeiro H et al., Biomedicine & Pharmacotherapy, 2022, DOI: 10.1016/j.biopha.2022.112958

  • The Portuguese Performance Assessment of Self-Care Skills Measure: Validity and Reliability
    Authors: Ferreira PL, Simões AL, Dourado M, Holm MB, Rogers JC
    Year: 2021
    Citation: Ferreira PL et al., OTJR: Occupation, Participation and Health, 2021, DOI: 10.1177/15394492211021309

  • Validity and Reliability of the Portuguese-Performance Assessment of Self-Care Skills (P-PASS) for Individuals with Disabilities
    Authors: Ferreira PL, Simões AL, Dourado M, Holm MB, Rogers JC
    Year: 2020
    Citation: Ferreira PL et al., Preprint, 2020, DOI: 10.21203/rs.3.rs-60570/v3

  • Knowledge of Palliative Care Among Medical Students of the University of Coimbra
    Authors: Oliveira S, Santiago LM, Dourado M
    Year: 2020
    Citation: Oliveira S et al., Acta Medica Portuguesa, 2020, DOI: 10.20344/amp.12590

  • Validity and Reliability of the Portuguese-Performance Assessment of Self-Care Skills (P-PASS) for Portuguese Individuals with Disabilities
    Authors: Ferreira PL, Simões AL, Dourado M, Holm MB, Rogers JC
    Year: 2020
    Citation: Ferreira PL et al., Preprint, 2020, DOI: 10.21203/rs.3.rs-53489/v1

Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional Profile 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevic’s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevic’s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem Güllü, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, Güllü Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

Published on by Global Scholar Awards

Dr. Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

CEO at CEFO, South Korea

Dr. Hyun-Sook Park is an accomplished researcher and leader in the fields of stem cell science, tissue engineering, and regenerative medicine. She holds a Ph.D. in Pathology from Imperial College London, where she focused on adult stem cells in the gastrointestinal tract. As the CEO of CEFO Bio Co., Ltd, Dr. Park has spearheaded innovations in stem cell therapies and bioengineering, with significant contributions to skin regeneration and pancreatic beta-cell differentiation. Her academic career includes roles as an affiliated professor at prestigious Korean universities. Dr. Park has held key leadership positions, including serving on boards for the Korea Society of Stem Cell Research and the Korean Tissue Engineering & Regenerative Medicine. She has received numerous awards, such as the British Council Ph.D. Award and Digital Innovation Award, recognizing her groundbreaking research. Dr. Park is also actively involved in shaping national policy on biomedical sciences and advancing global research initiatives.

Professional Profile

Education

Dr. Hyun-Sook Park has a distinguished academic background, with degrees from prestigious institutions. She earned her Bachelor of Science in Biology from Korea University in Seoul (1982-1986), followed by a Master of Science in Zoology from the same university (1986-1988). Dr. Park then pursued a Ph.D. in Pathology at Imperial College London, where she focused on adult stem cells in the gastrointestinal tract and their role in cancer development and regeneration. She completed her Ph.D. under the supervision of Dr. Nicholas A. Wright in 1997, at the Imperial College School of Medicine. Her research at Imperial College, specifically on gastrointestinal epithelial stem cells, marked the beginning of her long-standing interest in stem cell science. This educational foundation laid the groundwork for her future groundbreaking contributions to stem cell research, tissue engineering, and regenerative medicine, establishing her as a leader in the biomedical field.

Professional Experience

Dr. Hyun-Sook Park has an extensive professional career in biomedical research and leadership. She is the CEO of CEFO Bio Co., Ltd, where she oversees the company’s innovative work in stem cell therapies and bioengineering. Dr. Park’s research experience spans several prestigious institutions. She served as Vice Director at BioSolution (2007-2011), focusing on human embryonic stem cells and skin regeneration. Prior to this, she was Director of the Research Institute at MizMedi Hospital Medical Research Center (2005-2007), where she studied stem cell differentiation. Dr. Park also worked as a Senior Research Scientist at the Institute of Radiological and Medical Sciences (1999-2005), specializing in tissue engineering and pancreatic beta-cell differentiation. She has held postdoctoral roles, including at the Korea Research Institute of Bioscience and Biotechnology, and was a visiting researcher at the Imperial Cancer Research Fund. Her career has also included advisory roles and leadership in scientific committees and organizations.

Research Interests

Dr. Hyun-Sook Park’s research interests are centered around stem cell science, tissue engineering, and regenerative medicine. Her early work focused on adult stem cells in the gastrointestinal tract, exploring their role in cancer development and tissue regeneration. Over the years, she expanded her research to encompass a range of biomedical applications, including human embryonic stem cell differentiation, specifically in endodermal and mesodermal lineages. Dr. Park has made significant contributions to the development of bioartificial tissues, such as skin regeneration, and the differentiation of pancreatic beta cells from stem cells for potential diabetes treatments. Her research also explores gene therapy and the use of stem cells in cancer therapies. More recently, she has been involved in advanced techniques, such as the use of ultra-sensitive nanoparticles for tracking endothelial cells. Dr. Park’s work is crucial in advancing regenerative medicine and tissue engineering, with the potential to revolutionize treatments for various diseases.

Awards and Honors

Dr. Hyun-Sook Park has received numerous prestigious awards and honors throughout her career, recognizing her exceptional contributions to scientific research and innovation. Among her accolades is the British Council Ph.D. Award (1990) for her outstanding academic achievements. She also received the Digital Innovation Award in 2014 and 2017, acknowledging her pioneering work in stem cell research and regenerative medicine. Dr. Park was awarded the Overseas Research Scholarship Award (1990-1993) and the Weston Scholarship in the Royal Postgraduate Medical School (1990-1993), which supported her studies at Imperial College London. In addition to these awards, Dr. Park’s research has been consistently recognized by the scientific community, reflected in her extensive publication record and involvement in high-impact projects. Her leadership in the field is further highlighted by her membership in influential committees and advisory roles, shaping national policies in biomedical research. These honors underscore her significant impact on science and healthcare advancements.

Conclusion

Dr. Hyun-Sook Park is an outstanding candidate for the Women Researcher Award. With her exemplary leadership in bioengineering and stem cell research, she has made tremendous contributions to the scientific community. Her innovations in regenerative medicine and cancer research, along with her leadership in key professional and governmental committees, underline her profound impact on both science and policy. While there are opportunities for her to increase her global visibility and outreach, her achievements clearly demonstrate the caliber of a distinguished researcher deserving of this prestigious award.

Publications Top Noted

  • Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial
    • Authors: Baek, S.-H., Shim, B.-J., Won, H., Park, H.S., Kim, S.-Y.
    • Year: 2024
    • Citations: 0
  • Early Osteogenic-Induced Adipose-Derived Stem Cells and Canine Bone Regeneration Potential Analyzed Using Biodegradable Scaffolds
    • Authors: Yun, H.-H., Kim, S.-G., Park, S.-I., Hong, I.-H., Jeong, K.-S.
    • Year: 2023
    • Citations: 2
  • In Vitro Tracking of Human Umbilical Vein Endothelial Cells Using Ultra-Sensitive Quantum Dot-Embedded Silica Nanoparticles
    • Authors: Kim, J., Lee, S., Lee, Y.K., Jun, B.-H., Park, H.-S.
    • Year: 2023
    • Citations: 6
  • Comparison of Temperature Equilibrium Rate and Cell Growth/Viability Under Air Circulation in Cryogenic Storage Container
    • Authors: Park, J.-Y., Lee, D.-W., Lee, S., Park, H.-S., Yoon, G.-S.
    • Year: 2022
    • Citations: 0
  • Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells
    • Authors: Suh, D.H., Lee, S., Park, H.-S., Park, N.H.
    • Year: 2020
    • Citations: 4
  • Differentiation of Equine Induced Pluripotent Stem Cells into Mesenchymal Lineage for Therapeutic Use
    • Authors: Chung, M.-J., Park, S., Son, J.-Y., Park, H.-S., Jeong, K.-S.
    • Year: 2019
    • Citations: 19
  • Establishment of Stably Expandable Induced Myogenic Stem Cells by Four Transcription Factors
    • Authors: Lee, E.-J., Kim, M., Kim, Y.D., Hwang, D., Jeong, K.-S.
    • Year: 2018
    • Citations: 15
  • Recurrent Variations in DNA Methylation in Human Pluripotent Stem Cells and Their Differentiated Derivatives
    • Authors: Nazor, K.L., Altun, G., Lynch, C., Loring, J.F., Laurent, L.C.
    • Year: 2012
    • Citations: 316
  • The Effects of the Physical Properties of Culture Substrates on the Growth and Differentiation of Human Embryonic Stem Cells
    • Authors: Lee, S., Kim, J., Park, T.J., Kang, S., Park, H.-S.
    • Year: 2011
    • Citations: 29
  • Comparison of Mesenchymal-like Stem/Progenitor Cells Derived from Supernumerary Teeth with Stem Cells from Human Exfoliated Deciduous Teeth
    • Authors: Lee, S., An, S., Kang, T.H., Kwak, C.K., Park, H.-S.
    • Year: 2011
    • Citations: 29

Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Doctoral student at Shanghai Ruijin Hospital, China

Dr. Pengyi Liu is a dedicated researcher specializing in the tumor immune microenvironment of pancreatic cancer. Currently pursuing a doctoral degree at Ruijin Hospital, Shanghai Jiaotong University, Liu’s work focuses on understanding the roles of macrophages and T cells in tumor progression. With a Bachelor’s degree in Clinical Medicine, Liu has consistently excelled academically, earning numerous honors, including multiple scholarships and recognition as an “Outstanding Graduate.” Their research has led to significant publications in high-impact journals, exploring novel mechanisms in pancreatic cancer, such as macrophage differentiation and immune response modulation. Proficient in various experimental techniques like cell culture, flow cytometry, and molecular biology, Liu demonstrates a broad skill set essential for cutting-edge cancer research. Their collaborative efforts and innovative approaches continue to advance the field, offering potential new targets for diagnosis and treatment. Liu’s work holds promise for improving clinical outcomes in pancreatic cancer patients.

Professional Profile

Education

Dr. Pengyi Liu’s educational journey reflects a strong foundation in clinical medicine and research. He completed his Bachelor’s degree in Clinical Medicine at Shanghai Jiaotong University from 2016 to 2021, achieving a commendable GPA of 3.63. During this time, Liu was recognized for his academic excellence, earning multiple scholarships and being named a “Merit Student” in 2020. After completing his undergraduate studies, Liu continued his education at Ruijin Hospital, affiliated with Shanghai Jiaotong University School of Medicine, where he is currently pursuing a Doctor of Surgery degree under the prestigious “Zhiyuan Honors Program.” His research is guided by Prof. Baiyong Shen, focusing on the molecular mechanisms of pancreatic cancer. In addition to his rigorous academic training, Liu has taken a wide range of courses, including Anatomy, Physiology, Molecular Biology, Immunology, and Laboratory Animal Science, providing him with a well-rounded knowledge base for his advanced research.

Professional Experience

Dr. Pengyi Liu’s professional experience is centered around groundbreaking research in the field of pancreatic cancer. Currently a doctoral candidate at Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Liu is engaged in advanced research on the tumor immune microenvironment, particularly the roles of macrophages and T cells in tumor progression. Under the mentorship of Prof. Baiyong Shen, Liu has contributed to numerous high-impact publications on pancreatic cancer, including studies on macrophage differentiation, immune modulation, and tumor progression. His research projects are multifaceted, encompassing both molecular and animal model-based approaches to uncover novel mechanisms and potential therapeutic targets. Liu is proficient in various laboratory techniques, including cell culture, flow cytometry, molecular biology assays, and the construction of patient-derived xenograft and organoid models. His work continues to shape the understanding of pancreatic cancer, offering new insights into its diagnosis, treatment, and the development of targeted therapies.

Research Interests

Dr. Pengyi Liu’s research interests are centered around the tumor immune microenvironment, with a particular focus on pancreatic cancer. His work aims to understand the complex interactions between immune cells, such as macrophages and T cells, and tumor progression. Liu is dedicated to uncovering the molecular mechanisms that drive pancreatic cancer, especially how immune cells contribute to the tumor environment and influence cancer growth. His research explores the roles of various molecules, including lncRNAs and signaling pathways, in shaping the immune response and tumor microenvironment. By studying the molecular and cellular processes in pancreatic cancer, Liu aims to identify potential therapeutic targets for better diagnosis and treatment strategies. Additionally, Liu’s work involves the development and use of advanced experimental models, such as patient-derived xenografts and organoids, to simulate the tumor environment and test new treatment approaches. His goal is to bridge the gap between basic research and clinical application in oncology.

Awards and Honors

Dr. Pengyi Liu has received numerous awards and honors throughout his academic career, reflecting his exceptional performance and dedication to research. He was awarded the prestigious scholarships of Shanghai Jiaotong University in 2017, 2018, 2019, and 2020, which recognize his academic excellence. In 2020, he was named a “Merit Student,” further highlighting his outstanding achievements. Dr. Liu’s dedication to his studies was also acknowledged when he was recognized as an “Outstanding Graduate” in 2021, a testament to his strong academic record and research contributions. Additionally, as a graduate student, he was awarded the First-Class Scholarship in 2022 and the Second-Class Scholarship in 2023, underscoring his continued academic excellence and research productivity. These accolades demonstrate not only his commitment to excellence but also the recognition he has earned from his peers and academic community for his hard work and significant contributions to the field of medical research.

Conclusion

Pengyi Liu’s academic achievements, extensive research experience, and significant contributions to understanding the tumor immune microenvironment in pancreatic cancer make them a strong contender for the Best Researcher Award. With a clear focus on advancing scientific knowledge and potential for real-world impact, Liu exemplifies the qualities of a leading researcher. Continued diversification of their research scope and greater emphasis on clinical applications could further amplify their contributions to the field.

Publications Top Noted

  1. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, P., Sun, K., Wang, T., Shen, B.
    • Year: 2024
    • Journal: Cancer Cell International
    • Citations: 0
  2. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication
    • Authors: Chen, D., Liu, P., Lu, X., Li, H., Shen, B.
    • Year: 2024
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  3. ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma
    • Authors: Liu, Y., Cao, Y., Liu, P., Wang, W., Shen, B.
    • Year: 2024
    • Journal: Cellular Oncology
    • Citations: 2
  4. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
    • Authors: Cao, Y., Wang, X., Liu, Y., Jiang, L., Shen, B.
    • Year: 2024
    • Journal: Advanced Science
    • Citations: 3
  5. CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization
    • Authors: Liu, Y., Liu, P., Duan, S., Jiang, Y., Shen, B.
    • Year: 2024
    • Journal: Cell Death and Differentiation
    • Citations: 0
  6. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, Y., Liu, P., Bao, H., Lin, J.
    • Year: 2023
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  7. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer
    • Authors: Zhai, S., Lin, J., Ji, Y., Deng, X., Shen, B.
    • Year: 2023
    • Journal: Cell Discovery
    • Citations: 10
  8. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
    • Authors: Wang, L., Liu, Y., Dai, Y., Chen, S., Shen, B.
    • Year: 2023
    • Journal: Gut
    • Citations: 100
  9. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
    • Authors: Liu, Y., Shi, M., He, X., Sun, B., Shen, B.
    • Year: 2022
    • Journal: Journal of Hematology and Oncology
    • Citations: 76

Tingting Gao | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Tingting Gao | Medicine and Dentistry | Best Researcher Award

Doctor at Shanxi medical university, China

Dr. Tingting Gao is a dedicated and accomplished medical researcher with a strong focus on vascular surgery, immunometabolomics, and multimodal molecular imaging. She is currently pursuing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, where she works under the guidance of Professor Honglin Dong. With a broad range of research interests and expertise in cutting-edge imaging technologies, Dr. Gao has made significant contributions to the understanding of vascular diseases, atherosclerosis, and kidney injury. Her work bridges the gap between experimental biology and clinical applications, demonstrating a commitment to advancing both basic and translational research.

Professional Profile

Education

Dr. Tingting Gao is currently completing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, Taiyuan, China. She has been under the academic mentorship of Dr. Honglin Dong, MD, Ph.D., Assistant Dean of The Second Hospital of Shanxi Medical University. Her education has provided her with a strong foundation in both medical practice and research, allowing her to contribute to the field of vascular surgery while pursuing advanced studies in molecular medicine and disease mechanisms. Her educational journey emphasizes her dedication to both scientific inquiry and clinical expertise.

Professional Experience

Dr. Gao’s professional experience includes significant roles as a Research Assistant in the Department of Vascular Surgery at The Second Hospital of Shanxi Medical University, where she has worked from 2023 to the present. In this role, she conducts research focused on immunometabolomics and multimodal molecular imaging of vascular diseases. She has also worked as a subject participant in various research projects, such as the study of aortic aneurysms and contrast-induced acute kidney injury. Additionally, Dr. Gao has extensive clinical experience in vascular surgery, having worked from 2018 to 2022 in the same hospital, gaining hands-on expertise in patient care and surgical procedures.

Research Interests

Dr. Gao’s research interests span several domains, including vascular surgery, atherosclerosis, liver disease, and imaging technologies. She is particularly interested in the mechanisms underlying vascular diseases, such as atherosclerosis, and how substances like garlic can impact these conditions. Her work integrates network pharmacology, bioinformatics, and experimental verification to explore therapeutic pathways like ferroptosis. Additionally, she focuses on advanced imaging techniques, such as photoacoustic microscopy and magnetic nanoparticle imaging, to better understand disease mechanisms and improve diagnostic tools. Her multidisciplinary approach blends laboratory research with clinical applications, aiming to make a significant impact in both fields.

Awards and Honors

Dr. Gao has received recognition for her research contributions through various awards and honors. She has been a part of multiple funded projects, including those by the Shanxi Provincial Science and Technology Department and the Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi Province. These grants have supported her participation in cutting-edge research exploring vascular diseases, kidney injury, and novel imaging technologies. Dr. Gao’s dedication to her field has also been acknowledged by her peers, reflected in her impressive publication record and active participation in international conferences, where she has presented her findings at major forums like the World Molecular Imaging Society.

Conclusion

The individual appears highly deserving of the Best Researcher Award due to their comprehensive academic background, impressive publication record, technical expertise, and contributions to advanced research in vascular diseases, imaging technologies, and pharmacology. They have demonstrated creativity and leadership in scientific exploration, with innovative work that holds significant potential for clinical applications. However, future opportunities for growth could include assuming more independent leadership roles, increasing international recognition, and further advancing the clinical impact of their research.

Publications Top Noted

  1. Title: Highly sensitive magnetic particle imaging of abdominal aortic aneurysm NETosis with anti-Ly6G iron oxide nanoparticles
    Authors: Wang, H., Zhang, R., Jia, X., Hui, H., Dong, H.
    Year: 2024
    Citations: 0
  2. Title: Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study
    Authors: Gao, S., Gao, T., Li, L., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  3. Title: Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
    Authors: Wang, H., Tian, Q., Zhang, R., Zheng, G., Dong, H.
    Year: 2024
    Citations: 2
  4. Title: The Protective Role of Intermedin in Contrast-Induced Acute Kidney Injury: Enhancing Peritubular Capillary Endothelial Cell Adhesion and Integrity Through the cAMP/Rac1 Pathway
    Authors: Gao, T., Gu, R., Wang, H., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  5. Title: The Down-Shifting Luminescence of Rare-Earth Nanoparticles for Multimodal Imaging and Photothermal Therapy of Breast Cancer
    Authors: Gao, T., Gao, S., Li, Y., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  6. Title: Case Report: The application of novel imaging technologies in lower extremity peripheral artery disease: NIR-II imaging, OCTA, and LSFG
    Authors: Ning, Y., Hu, J., Li, H., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  7. Title: Garlic ameliorates atherosclerosis by regulating ferroptosis pathway: an integrated strategy of network pharmacology, bioinformatic and experimental verification
    Authors: Gao, T., Gao, S., Wang, H., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  8. Title: Metabolomics and network pharmacology exploration of the effects of bile acids on carotid atherosclerosis and potential underlying mechanisms
    Authors: Cheng, X., Zhang, R., Qi, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  9. Title: High estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype resulting in aortic inflammation via inhibiting VHL/HIF1a/KLF4 axis
    Authors: Zhang, R., Wang, H., Cheng, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  10. Title: Neutrophil Extracellular Traps Aggravate Contrast-Induced Acute Kidney Injury by Damaging Glomeruli and Peritubular Capillaries
    Authors: Wang, H., Gao, T., Zhang, R., Zheng, G., Dong, H.
    Year: 2023
    Citations: 5

Guoping Zheng | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Guoping Zheng | Medicine and Dentistry | Best Researcher Award

Laboratory head at University of Sydney (WIMR), Australia

Associate Professor Guoping Zheng is a renowned researcher and academic in the field of medicine, specializing in kidney injury, repair, and fibrosis. He is currently an Associate Professor at the University of Sydney, within the Faculty of Medicine and Health, and holds a prestigious NHMRC Principal Research Fellowship at the Westmead Institute for Medical Research. Dr. Zheng has led pioneering research projects in kidney transplantation, fibrosis, and inflammatory diseases, contributing significantly to our understanding of kidney pathophysiology and potential therapeutic interventions. With a research portfolio that spans over two decades, Dr. Zheng has garnered international recognition for his innovative work in renal medicine, including developing engineered macrophages for treating chronic kidney disease. His research impact is further demonstrated by his high citation index, editorial roles in top journals, and his numerous academic and institutional leadership positions.

Professional Profile

Education

Dr. Guoping Zheng has an impressive educational background in medical and molecular sciences. He earned his PhD from the University of Sydney’s Faculty of Medicine, where he conducted research from 1998 to 2002. Before that, he completed a Master of Medicine by research at Shanxi Medical University in China, specializing in biochemistry and molecular biology from 1985 to 1988. Dr. Zheng also holds an MBBS degree from the same institution, completed in 1985. His educational journey laid a strong foundation for his future research and teaching career, enabling him to contribute extensively to the understanding of kidney disease, renal fibrosis, and related inflammatory processes.

Professional Experience

Dr. Zheng has held a distinguished academic career, with extensive roles at the University of Sydney and the Westmead Institute for Medical Research (WIMR). Since 2003, he has been a key figure at the Centre for Transplantation and Renal Research, where he currently serves as an Associate Professor and leads the Kidney Injury Repair and Fibrosis Study Group. His prior roles include Senior Research Officer and Research Officer, with a focus on kidney pathology. Dr. Zheng has also been an NHMRC Peter Doherty Fellow and a lecturer at the University of Sydney. His professional trajectory reflects a deep commitment to advancing medical research and education, particularly in the field of nephrology and renal transplantation. Additionally, Dr. Zheng has held several executive committee positions at WIMR and serves as a mentor and reviewer for multiple research bodies and academic institutions globally.

Research Interests

Dr. Zheng’s research focuses on kidney injury, repair mechanisms, and fibrosis, particularly in the context of chronic kidney disease and renal transplantation. His work aims to uncover novel therapeutic strategies for kidney fibrosis, a key driver of kidney failure. Dr. Zheng has explored several molecular pathways, including the role of macrophages, TGF-β signaling, and matrix metalloproteinases in fibrosis and inflammation. His research also investigates the potential of engineered cells, such as chimeric antigen receptor macrophages, to prevent kidney damage. Another significant area of interest includes the differentiation of pro-fibrotic from anti-inflammatory effects of TGF-β in kidney fibrosis, which may lead to more effective treatments for renal diseases. Dr. Zheng’s interdisciplinary approach bridges biochemistry, molecular biology, and clinical medicine, advancing both basic science and therapeutic innovation in renal health.

Awards and Honors

Dr. Zheng has received numerous awards and honors throughout his distinguished career, recognizing his outstanding contributions to medical research. He has been awarded the prestigious Westmead Millennium Institute Science Prize five times (2006, 2010, 2013, 2017, and 2021), which is granted to the best original research within his institution. Additionally, he was a finalist for the Basic Science Award at both the 55th ANZSN Annual Scientific Meeting (2020) and the 5th Asian Pacific Congress of Nephrology (2016). Dr. Zheng has also received various recognitions for his poster presentations and research symposia, including multiple “Best Poster Presentation Prizes” at the Annual Research Symposium during Hospital Week. These honors reflect his ongoing dedication to advancing scientific understanding in nephrology and transplantation. Moreover, he has been recognized internationally with travel awards and fellowships, including the New Investigator Travel Award for the Pan-Pacific Connective Tissue Societies Symposium in 1999.

Conclusion

Associate Professor Guoping Zheng stands as a highly suitable candidate for the Best Researcher Award. His extensive research experience, influential publications, multiple awards, and leadership in renal medicine demonstrate a strong commitment to advancing medical knowledge and treatment options for kidney disease. Areas of further development, such as advancing his work’s clinical translation and expanding international collaborations, could add even more depth to his already impressive career. Overall, Dr. Zheng’s accomplishments, recognized expertise, and continuous contributions make him a deserving candidate for this prestigious recognition.

Publications Top Noted

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
    • Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, …
    • Year: 2021
    • Citations: 10,941
  2. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
    • Authors: DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, …
    • Year: 2008
    • Citations: 2,962
  3. E‐Cadherin/β‐Catenin Complex and the Epithelial Barrier
    • Authors: X Tian, Z Liu, B Niu, J Zhang, TK Tan, SR Lee, Y Zhao, DCH Harris, …
    • Year: 2011
    • Citations: 610
  4. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease
    • Authors: Y Wang, YP Wang, G Zheng, VWS Lee, L Ouyang, DHH Chang, …
    • Year: 2007
    • Citations: 449
  5. IL-10/TGF-β–modified macrophages induce regulatory T cells and protect against adriamycin nephrosis
    • Authors: Q Cao, Y Wang, D Zheng, Y Sun, Y Wang, VWS Lee, G Zheng, TK Tan, …
    • Year: 2010
    • Citations: 319
  6. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-β1 in renal tubular epithelial …
    • Authors: G Zheng, JG Lyons, TK Tan, Y Wang, TT Hsu, D Min, L Succar, …
    • Year: 2009
    • Citations: 286
  7. Characterization of murine macrophages from bone marrow, spleen and peritoneum
    • Authors: C Wang, X Yu, Q Cao, Y Wang, G Zheng, TK Tan, H Zhao, Y Zhao, …
    • Year: 2013
    • Citations: 273
  8. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease
    • Authors: J Lu, QI Cao, D Zheng, Y Sun, C Wang, X Yu, YA Wang, VWS Lee, …
    • Year: 2013
    • Citations: 254
  9. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells
    • Authors: TK Tan, G Zheng, TT Hsu, Y Wang, VWS Lee, X Tian, Y Wang, Q Cao, …
    • Year: 2010
    • Citations: 185
  10. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases
    • Authors: H Zhao, Y Dong, X Tian, TK Tan, Z Liu, Y Zhao, Y Zhang, DCH Harris, …
    • Year: 2013
    • Citations: 177
  11. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage
    • Authors: T Kui Tan, G Zheng, TT Hsu, S Ra Lee, J Zhang, Y Zhao, X Tian, Y Wang, …
    • Year: 2013
    • Citations: 175
  12. CD4+ CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease
    • Authors: D Mahajan, Y Wang, X Qin, Y Wang, G Zheng, YM Wang, SI Alexander, …
    • Year: 2006
    • Citations: 173
  13. Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury
    • Authors: Q Cao, Y Wang, Z Niu, C Wang, R Wang, Z Zhang, T Chen, XM Wang, …
    • Year: 2018
    • Citations: 114
  14. Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy
    • Authors: Q Cao, Y Wang, XM Wang, J Lu, VWS Lee, Q Ye, H Nguyen, G Zheng, …
    • Year: 2015
    • Citations: 112
  15. Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus
    • Authors: D Zheng, Y Wang, Q Cao, VWS Lee, G Zheng, Y Sun, TK Tan, Y Wang, …
    • Year: 2011
    • Citations: 100

Napoliane Santos | Medicine and Dentistry | Women Researcher Award

Published on by Global Scholar Awards

Mrs. Napoliane Santos | Medicine and Dentistry | Women Researcher Award

Medica at Intituto brasileiro de medicina regenerativa, Brazil

Dr. Napoliane Costa Santos is a skilled radiologist and ultrasonography specialist with extensive experience in patient-focused diagnostic imaging. Driven by a commitment to provide compassionate care, she combines her technical expertise with a mission to ensure that patients feel comfortable and well-supported during their medical exams. Her career spans over a decade, during which she has contributed significantly to multiple healthcare institutions, specializing in general ultrasonography, pain intervention, and regenerative medicine. Her dedication to patient care and her proactive approach in advanced medical imaging make her a standout professional in her field. Additionally, she is deeply involved in medical education, where she shares her expertise with emerging healthcare professionals, furthering the field of ultrasonography and enhancing patient outcomes through her leadership.

Professional Profile

Education

Dr. Santos has a well-rounded educational background, beginning with her medical degree from the Universidade do Estado do Pará in 2012. Following this, she completed a medical residency at Hospital Maternidade Frei Galvão, a program accredited by the Brazilian College of Radiology. Her formal education continued with specialized certifications, including a Diagnostic Imaging specialization in General Ultrasonography, recognized by a national board in 2018. More recently, she pursued postgraduate studies in pain intervention and regenerative medicine at Orthoregen, Brazil, enhancing her expertise in minimally invasive techniques for pain relief. Other certifications include postgraduate work in musculoskeletal imaging, thermography, and clinical pain, showing her continuous pursuit of knowledge and advanced skills in radiology and ultrasonography.

Professional Experience

Dr. Santos’s career is marked by her longstanding roles in numerous reputable healthcare settings. Since 2013, she has been an ultrasonography specialist at Hospital Maternidade Frei Galvão in Guaratinguetá, where she performs general ultrasound exams. Her expertise in pain intervention led her to positions at Clínica Moverti and Hospital Policlin in São Paulo, where she has practiced since 2019 and 2017, respectively. Additionally, she contributes to the BIRM Instituto Brasileiro de Medicina Regenerativa and Orthoregen, focusing on clinical research, pain intervention, and regenerative medicine. At Orthoregen, she also serves as an instructor, training other healthcare providers in advanced ultrasonography techniques, further broadening her impact within the field.

Research Interests

Dr. Santos’s research interests are centered on the applications of diagnostic imaging in managing chronic pain and regenerative medicine. Her focus on ultrasonography-guided, minimally invasive pain treatments addresses a significant area in modern healthcare, particularly for patients with musculoskeletal disorders. She is especially interested in exploring how advancements in ultrasonography can enhance patient outcomes in musculoskeletal and rheumatologic conditions. Her work at Orthoregen and BIRM reflects her dedication to integrating clinical research with practical applications, aiming to advance the fields of pain intervention and regenerative medicine. Through ongoing studies and clinical practices, she continues to contribute to research that seeks innovative, non-invasive solutions for chronic pain.

Awards and Honors

While Dr. Santos has yet to receive major publicized awards, her growing expertise and roles in esteemed institutions highlight her accomplishments. Her board certification as a Diagnostic Imaging Specialist by the Brazilian College of Radiology reflects a high level of professional recognition. Her responsibilities as an instructor in ultrasonography and pain intervention signify trust in her abilities to lead and mentor, which is a significant professional honor. As her clinical and research contributions gain visibility, Dr. Santos stands poised for recognition in healthcare and research awards, particularly those honoring advancements in diagnostic radiology and compassionate patient care. Her dedication to her field is evident, positioning her as a respected professional and potential candidate for future honors.

Conclusion

Napoliane Costa Santos possesses a strong foundation for the Women Researcher Award due to her depth of clinical expertise, specialized training in ultrasonography and pain management, and commitment to patient care. She demonstrates both technical skill and compassionate care, essential qualities in healthcare research and practice. However, to strengthen her candidacy, a greater focus on documented research contributions, leadership in scientific projects, and published innovations would be advantageous. Overall, she is a promising candidate with potential to make a meaningful impact through further academic and research pursuits in her field.

Publications Top Noted

  1. SDIMMMER: A Proposed Clinical Approach to Optimize Cellular Physiology in Regenerative Medicine
    • Authors: Lana, J.V., Lana, J.F., Melo, G., Pires, L., Tambeli, C.H.
    • Year: 2024
    • Citation Count: 0
  2. Regenerative Inflammation: The Mechanism Explained from the Perspective of Buffy-Coat Protagonism and Macrophage Polarization
    • Authors: Martins, R.A., Costa, F.R., Pires, L., Kruel, A., Lana, J.F.
    • Year: 2024
    • Citation Count: 0
  3. Nebulized Glutathione as a Key Antioxidant for the Treatment of Oxidative Stress in Neurodegenerative Conditions
    • Authors: Lana, J.V., Rios, A., Takeyama, R., Purita, J., Lana, J.F.
    • Year: 2024
    • Citation Count: 3
  4. The Biological Role of Platelet Derivatives in Regenerative Aesthetics
    • Authors: Santos, L.C., Lana, G.L., Santos, G.S., Tambeli, C.H., Lana, J.F.
    • Year: 2024
    • Citation Count: 4
  5. Sacral Bioneuromodulation: The Role of Bone Marrow Aspirate in Spinal Cord Injuries
    • Authors: Lana, J.F., Navani, A., Jeyaraman, M., de Moraes Ferreira Jorge, D., Purita, J.
    • Year: 2024
    • Citation Count: 0
  6. The Role of Orthobiologics in Chronic Wound Healing
    • Authors: Domingues, R.B., von Rautenfeld, M., Kavalco, C.M., Everts, P., Lana, J.F.
    • Year: 2024
    • Citation Count: 4

Olgica Mihaljevic | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Olgica Mihaljevic | Medicine and Dentistry | Best Researcher Award

Prof at University of Kragujevac, Serbia, Faculty of Medical sciences, Department of Pathophysiology, Serbia

Prof. Olgica Mihaljevic, a distinguished medical researcher and educator, specializes in pathophysiology with a focus on internal medicine, carcinoma, thyroid diseases, and public health. She earned her PhD with a thesis on apoptosis and oxidative stress in thyroid carcinoma patients, showcasing her expertise in cellular mechanisms related to cancer. With over 15 years of experience, Mihaljevic has held various academic positions, including her current role as head of the pathophysiology department, and teaches at the Military Medical Academy in Belgrade. Her research contributions are extensive, addressing critical health issues like COVID-19, cancer screening, and healthcare disparities. A committed member of professional bodies, she is vice president of the Pathophysiology Section of the Serbian Medical Association. Mihaljevic’s work in high-impact areas and dedication to medical education and public health make her a highly respected figure in Serbia’s medical community and a strong candidate for research accolades.

Professional Profile

Education

Prof. Olgica Mihaljevic completed her medical education at the Faculty of Medical Sciences, University of Kragujevac, where she earned her medical degree in 2007 with an impressive average grade of 9.83. Following her undergraduate studies, she pursued postgraduate education in Clinical and Experimental Internal Medicine at the same institution, achieving an average grade of 9.0. In 2014, she completed her PhD with a thesis focused on the changes in apoptosis of lymphocytes, oxidative stress parameters, and cytokine profiles in patients with differentiated thyroid carcinoma. This research highlighted her expertise in understanding the molecular and biochemical mechanisms behind thyroid diseases and cancer. Her academic journey has been marked by excellence, reflected in both her grades and the depth of her research in critical areas of internal medicine, oncology, and public health. Prof. Mihaljevic’s strong educational background laid the foundation for her successful academic and professional career.

Professional Experience

Prof. Olgica Mihaljevic has over 15 years of professional experience in both research and education. She began her academic career in 2008 as a teaching assistant in the Department of Pathophysiology at the Faculty of Medical Sciences, University of Kragujevac, where she progressed to assistant and later assistant professor by 2016. During this time, she contributed to the education of medical students and the development of curriculum in pathophysiology. In 2017, she became the head of the Department of Pathophysiology in basic dental studies and later took on a role as a lecturer at the Military Medical Academy in Belgrade. In 2023, she was appointed head of the Department of Pathophysiology for basic medical studies in English at the University of Kragujevac. In addition to her academic roles, Mihaljevic is actively involved in medical research, publishing extensively on topics such as cancer, oxidative stress, and public health.

Research Interests

Prof. Olgica Mihaljevic’s research interests span several critical areas of medicine, with a strong focus on internal medicine, dermatology, and oncology. Her work primarily investigates the pathophysiology of thyroid gland diseases, particularly thyroid carcinoma, where she explores cellular mechanisms like apoptosis, oxidative stress, and cytokine profiles. Additionally, she studies the molecular aspects of autoimmune diseases, nephrology, and radiotherapy. Mihaljevic has a keen interest in the role of genome damage in disease progression, especially in cancer. She is also committed to understanding the broader impacts of public health, focusing on the sociodemographic factors influencing cancer screenings and healthcare access. Her research aims to bridge the gap between clinical practices and molecular biology, improving patient care and disease management. Prof. Mihaljevic’s contributions are especially relevant in addressing major health challenges like cancer, autoimmune disorders, and the effects of oxidative stress, making her research crucial to both medical science and public health.

Awards and Honors

Prof. Olgica Mihaljevic has earned numerous accolades throughout her career, reflecting her dedication to research and education in the medical field. As a highly respected academic, she has been recognized for her contributions to pathophysiology and public health. Prof. Mihaljevic holds several key leadership roles in professional medical organizations, including being a vice president of the Pathophysiology Section of the Serbian Medical Association. She is also an active member of the Serbian Medical Society and the Medical Chamber of Serbia. Her commitment to advancing medical science is evident in her editorial role on the Medical Journal of the Serbian Medical Society, where she contributes to the dissemination of critical research. Through her research, especially in cancer, oxidative stress, and healthcare disparities, Prof. Mihaljevic has garnered recognition from both national and international medical communities. Her academic and research achievements solidify her reputation as a leader in her field.

Conclusion

Olgica Mihaljevic is a highly qualified candidate for the Best Researcher Award, given her extensive expertise, research contributions, and leadership in medical sciences. Her focus on significant health issues like carcinoma, oxidative stress, and public health aligns well with the award’s purpose of recognizing impactful medical research. With strategic enhancements in international collaboration and funding acquisition, she could further amplify her contributions to the field. Overall, Mihaljevic demonstrates the attributes and achievements that make her a worthy candidate for this awar

Publications Top Noted

  • Title: Laboratory Puzzle of Oxidative Stress, Parameters of Hemostasis and Inflammation in Hospitalized Patients with COVID-19
    Authors: Djordjevic, J., Ignjatovic, V., Vukomanovic, V., Stanojevic Pirkovic, M., Mihaljevic, O.
    Journal: Biomedicines
    Year: 2024
    Volume: 12(3), 636
    Citations: 1
  • Title: Socioeconomic and Health Characteristics as Predictors of Social Support in Elderly People with Visual Impairment: Evidence from Serbia
    Authors: Djurovic, N., Radovanovic, S., Mihaljevic, O., Vasiljevic, D., Selakovic, V.
    Journal: Iranian Journal of Public Health
    Year: 2024
    Volume: 53(10), 2251-2259
    Citations: 0
  • Title: Sociodemographic Factors Associated with Breast Cancer Screening Among Women in Serbia, National Health Survey
    Authors: Djordjević, S., Dimitrijev, I., Boričić, K., Sorak, M., Jovanović, V.
    Journal: Iranian Journal of Public Health
    Year: 2024
    Volume: 53(2), 387–396
    Citations: 0
  • Title: Transforming Growth Factor Beta 1 (TGF-β1) in COVID-19 Patients: Relation to Platelets and Association with the Disease Outcome
    Authors: Zivancevic-Simonovic, S., Minic, R., Cupurdija, V., Jakovljevic, V., Mihaljevic, O.
    Journal: Molecular and Cellular Biochemistry
    Year: 2023
    Volume: 478(11), 2461–2471
    Citations: 6
  • Title: Oxidative Stress and DNA Damage in Critically Ill Patients with Sepsis
    Authors: Mihaljevic, O., Zivancevic-Simonovic, S., Jovanovic, D., Jakovljevic, V., Milosevic-Djordjevic, O.
    Journal: Mutation Research – Genetic Toxicology and Environmental Mutagenesis
    Year: 2023
    Volume: 889, 503655
    Citations: 2
  • Title: Effect of the COVID-19 Pandemic on Surgery for Indeterminate Thyroid Nodules (THYCOVID): A Retrospective, International, Multicenter, Cross-sectional Study
    Authors: Medas, F., Dobrinja, C., Al-Suhaimi, E.A., Zahid, M.T., Zielke, A., Mihaljevic, O.
    Journal: The Lancet Diabetes and Endocrinology
    Year: 2023
    Volume: 11(6), 402–413
    Citations: 11
  • Title: Pathophysiological and Laboratory Aspects of Hemostatic Disorders in Patients with COVID-19
    Authors: Đorđević, J., Mihaljević, O., Pirković, M.S., Radović, M., Babović, B.
    Journal: Acta Facultatis Medicae Naissensis
    Year: 2023
    Volume: 40(4), 402–414
    Citations: 0
  • Title: Demographic and Socioeconomic Factors Associated with Cervical Cancer Screening Among Women in Serbia
    Authors: Djordjevic, S., Boricic, K., Radovanovic, S., Mihaljevic, O., Jovanovic, V.
    Journal: Frontiers in Public Health
    Year: 2023
    Volume: 11, 1275354
    Citations: 1